Conformational diversity of catalytic cores of protein kinases

Pharmacology and Therapeutics

Volumn 82, Issue 2-3, 1999, Pages 157-164

  Sowadski, Janusz M ^a   Epstein, Linda F ^a   Lankiewicz, Leszek ^a   Karlsson, Rolf ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATP binding; Conformational diversity; protein crystallography; Protein kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE;

CONFERENCE PAPER; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; X RAY CRYSTALLOGRAPHY;

ANIMALS; CATALYTIC DOMAIN; FORECASTING; HUMANS; MOLECULAR STRUCTURE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES;

EID: 0033025368     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00054-0     Document Type: Conference Paper

References (43)

1. Abola E.E., Sussman J.L., Prilusky J., Manning N.O. Protein data bank archives of three-dimensional macromolecular structures. Methods Enzymol. 277:1997;556-571.
2. 2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24). EMBO J. 12:1993;849-859.
3. Canagarajah B.J., Khokhlatchev A., Cobb M.J., Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell. 90:1997;859-869.
4. de Azevedo W.F. Jr., Mueller-Dieckmann H.J., Schulze-Gahmen U., Worland P.J., Sausville E., Kim S.H. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc. Natl. Acad. Sci. USA. 93:1996;2735-2740.
5. de Azevedo W.F., Leclerc S., Meijer L., Havlicek L., Strnad M., Kim S.H. Inhibition of cyclin-dependent kinases by purine analogues. crystal structure of human cdk2 complexed with roscovitine Eur. J. Biochem. 243:1997;518-526.
6. De Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O., Kim S.H. Crystal structure of cyclin-dependent kinase 2. Nature. 363:1993;595-602.
7. Engh R.A., Girod A., Kinzel V., Huber R., Bossemeyer D. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J. Biol. Chem. 271:1996;26157-26164.
8. Furet P., Caravetti G., Lydon N., Priestle J.P., Sowadski J.M., Trinks U., Traxler P. Modeling study of protein kinase inhibitors. binding mode of staurosporine and origin of the selectivity of CGP 52411 J. Comput. Aided Mol. Des. 9:1995;465-472.
9. Goldberg J., Nairn A.C., Kuriyan J. Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell. 84:1996;875-887.
10. Hubbard S.R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16:1997;5572-5581.
11. Hubbard S.R., Wei L., Ellis L., Hendrickson W.A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature. 372:1994;746-754.
12. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massague J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 376:1995;313-320.
13. Karlsson R., Madhusudan Taylor, and Sowadski S.S. Crystal structure of the mammalian catalytic subunit of cAMP-dependent protein kinase and an inhibitor peptide display an open conformation. Acta Crystallogr. D. 49:1993;381-388.
14. Karlsson R.F., Madhusudan Taylor, and Sowadski S.S. Intermolecular contacts in various crystal forms related to the open and closed conformation states of the catalytic subunit of cAMP-dependent protein kinase. Acta Crystallogr. D. 50:1994;657-662.
15. Knighton D.R., Zheng J., Ten Eyck L.F., Ashford V.A., Xuong N.-H., Taylor S.S., Sowadski J.M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate dependent protein kinase. Science. 253:1991;407-414. a.
16. Knighton D.R., Zheng J., Ten Eyck L.F., Xuong N.-H., Taylor S.S., Sowadski J.M. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 253:1991;414-420. b.
17. Knighton D.R., Bell S., Zheng J., Ten Eyck L.F., Xuong N.-H., Taylor S.S., Sowadski J.M. 2.0Å refined crystal structure of the catalytic subunit of cAMP-dependent protein kinases complexed with a peptide inhibitor and detergent. Acta Crystallogr. D. 49:1993;357-361.
18. Lawrie A.M., Noble M.E., Tunnah P., Brown N.R., Johnson L.N., Endicott J.A. Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nature Struct. Biol. 4:1997;796-801.
19. Madhusudan, Trafny, E. A., Xuong, N. H., Adams, J. A., Ten Eyck, L. F., Taylor, S. S. and Sowadski, J. M. (1994) cAMP-dependent protein kinase: crystallographic insights into substrate recognition and phosphotransfer. Protein Sci. 3: 176-187.
20. Mohammadi M., Schlessinger J., Hubbard S.R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 86:1996;577-587.
21. Mohammadi M., McMahon G., Sun L., Tang C., Hirth P., Yeh B.K., Hubbard S.R., Schlessinger J. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science. 276:1997;955-960.
22. Narayana N., Cox S., Nguyen-huu X., Ten Eyck L.F., Taylor S.S. A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. Structure. 5:1997;921-935. a.
23. Narayana N., Cox S., Shaltiel S., Taylor S.S., Xuong N. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. Biochemistry. 36:1997;4438-4448. b.
24. Niefind K., Guerra B., Pinna L.A., Issinger O.G., Schomburg D. Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 Å resolution. EMBO J. 17:1998;2451-2462.
25. Owen D.J., Noble M.E., Garman E.F., Papageorgiou A.C., Johnson L.N. Two structures of the catalytic domain of phosphorylase kinase. an active protein kinase complexed with substrate analogue and product Structure. 3:1995;467-482.
26. Prade L., Engh R.A., Girod A., Kinzel V., Huber R., Bossemeyer D. Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential. Structure. 5:1997;1627-1637.
27. Russo A.A., Jeffrey P.D., Pavletich N.P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nature Struct. Biol. 3:1996;696-700.
28. Sayles R.A., Milner-White E.J. RasMol. biomolecular graphics for all Trends Biochem. Sci. 20:1995;374-376.
29. Schulze-Gahmen U., Brandsen J., Jones H.D., Morgan D.O., Meijer L., Vesely J., Kim S.H. Multiple modes of ligand recognition. crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine Proteins. 22:1995;378-391.
30. Sicheri F., Moarefi I., Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature. 385:1997;602-609.
31. Toledo L.M., Lydon N.B. Structures of staurosporine bound to CDK2 and cAPK - new tools for structure-based design of protein kinase inhibitors. Structure. 5:1997;1551-1556.
32. Tong L., Pav S., White D.M., Rogers S., Crane K.M., Cywin C.L., Brown M.L., Pargellis C.A. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nature Struct. Biol. 4:1997;311-316.
33. Wang Z., Harkins P.C., Ulevitch R.J., Han J., Cobb M.H., Goldsmith E.J. The structure of mitogen-activated protein kinase p38 at 2.1 Å resolution. Proc. Natl. Acad. Sci. USA. 94:1997;2327-2332.
34. Williams J.C., Weijland A., Gonfloni S., Thompson A., Courtneidge S.A., Superti-Furga G., Wierenga R.K. The 2.35 Å crystal structure of the inactivated form of chicken Src. a dynamic molecule with multiple regulatory interactions J. Mol. Biol. 274:1997;757-775.
35. Wilson K.P., McCaffrey P.G., Hsiao K., Pazhanisamy S., Gelullo V., Bemis G.W., Fitzgibbons M.J., Caron P.R., Murcko M.A., Su M.S.S. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol. 4:1997;423-431.
36. Xu R.M., Carmel G., Sweet R.M., Kuret J., Cheng X. Crystal structure of casein kinase-1, a phosphate-directed protein kinase. EMBO J. 14:1995;1015-1023.
37. Xu R.M., Carmel G., Kuret J., Cheng X. Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors. Proc. Natl. Acad. Sci. USA. 93:1996;6308-6313.
38. Xu W., Harrison S.C., Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:1997;595-602.
39. Yamaguchi H., Hendrickson W.A. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature. 384:1996;484-489.
40. Zhang F., Strand A., Robbins D., Cobb M.H., Goldsmith E.J. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature. 367:1994;704-711.
41. Zheng J.-H., Knighton D.R., Ten Eyck L.F., Karlsson R., Xuong N.-H., Taylor S.S., Sowadski J.M. Structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochemistry. 32:1993;2154-2161. a.
42. Zheng J., Knighton D.R., Xuong N.-H., Taylor S.H., Sowadski J.M., Ten Eyck L.F. Crystal structure of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Sci. 2:1993;1559-1573. b.
43. Zheng J.H., Trafny E.A., Knighton D.R., Xuong N.-H., Taylor S.S., Ten Eyck L.F., Sowadski J.M. 2.2Å refined crystal structure of the catalytic subunit of cAMP-dependent protein kinases complexed with MnATP and a peptide inhibitor. Acta Crystallogr. D. 49:1993;362-365. c.